Recombinant human OX40/TNFRSF4 protein

Cat No.
ATGP4045

Size

QTY

List Price

10ug

USD 140


20ug

USD 250

50ug

USD 330

100ug

USD 550

250ug

USD 960

500ug

USD 1,640

1mg

USD 2,730

USD 0



Product Information

Product Type
Recombinant Protein
Expression System
Baculovirus
Domain
29-214aa
UniProt No.
P43489
NCBI Accession No.
NP_003318.1
Alternative names
Tumor necrosis factor receptor superfamily member 4, TNFRSF4, ACT35, CD134, IMD16, OX40, TXGP1L, ACT35 antigen, OX40L receptor, TAX transcriptionally-activated glycoprotein 1 receptor

Product Specification

Molecular Weight
46.9KDa (425aa)
Concentration
0.5mg/ml (determined by absorbance at 280nm)
Formulation
Liquid in. Phosphate-Buffered Saline (pH 7.4) containing 10% glycerol
Purity
> 90% by SDS-PAGE
Bioactivity
Measured by its binding ability in a functional ELISA with mouse OX40 Ligand/TNFSF4 (CAT# ATGP4022). The ED50 range ≤ 0.15 ug/ml.
Endotoxin
< 1 EU per 1ug of protein (determined by LAL method)
Tag
hIgG-His-Tag
Applications
SDS-PAGE, Bioactivity
Storage
Can be stored at +2C to +8C for 1 week. For long term storage, aliquot and store at -20C to -80C. Avoid repeated freezing and thawing cycles.

Data

SDS-PAGE

3ug by SDS-PAGE under reducing condition and visualized by coomassie blue stain

Biological Activity

Mouse OX40 Ligand/TNFSF4 (CAT# ATGP4022) is coated at 1 ug/ml (100 ul/well) can bind Human TNFRSF4. The ED50 range ≤ 0.15 ug/ml.

Note: For research use only. This product is not intended or approved for human, diagnostics or veterinary use.